Fate Therapeutics, Inc. (FATE)
2.11
+0.02
(+0.96%)
USD |
NASDAQ |
Oct 23, 16:00
2.11
0.00 (0.00%)
After-Hours: 20:00
Fate Therapeutics Price : 2.11 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 2.08 | 2.135 | 2.015 | 2.11 | 1.111M |
| Oct 22, 2026 | 2.07 | 2.11 | 2.035 | 2.09 | 867181.0 |
| Oct 21, 2026 | 2.06 | 2.14 | 2.045 | 2.07 | 1.215M |
| Oct 20, 2026 | 1.86 | 2.145 | 1.84 | 2.06 | 1.772M |
| Oct 19, 2026 | 1.79 | 1.90 | 1.75 | 1.86 | 1.684M |
| Oct 16, 2026 | 1.94 | 1.975 | 1.78 | 1.79 | 1.384M |
| Oct 15, 2026 | 1.96 | 1.995 | 1.91 | 1.925 | 1.158M |
| Oct 14, 2026 | 1.95 | 1.99 | 1.89 | 1.94 | 1.674M |
| Oct 13, 2026 | 2.13 | 2.13 | 1.98 | 2.00 | 953482.0 |
| Oct 12, 2026 | 2.13 | 2.18 | 2.104 | 2.13 | 616846.0 |
| Oct 09, 2026 | 2.13 | 2.275 | 2.10 | 2.18 | 773467.0 |
| Oct 08, 2026 | 2.12 | 2.13 | 2.03 | 2.13 | 1.476M |
| Oct 07, 2026 | 2.28 | 2.30 | 2.14 | 2.15 | 863012.0 |
| Oct 06, 2026 | 2.43 | 2.49 | 2.285 | 2.29 | 1.136M |
| Oct 05, 2026 | 2.32 | 2.575 | 2.29 | 2.43 | 3.381M |
| Oct 02, 2026 | 2.34 | 2.36 | 2.27 | 2.32 | 658023.0 |
| Oct 01, 2026 | 2.37 | 2.39 | 2.285 | 2.30 | 812977.0 |
| Sep 30, 2026 | 2.40 | 2.495 | 2.355 | 2.37 | 1.078M |
| Sep 29, 2026 | 2.37 | 2.41 | 2.29 | 2.38 | 1.443M |
| Sep 28, 2026 | 2.30 | 2.42 | 2.27 | 2.38 | 1.157M |
| Sep 25, 2026 | 2.34 | 2.465 | 2.27 | 2.35 | 3.387M |
| Sep 24, 2026 | 2.43 | 2.43 | 2.27 | 2.33 | 1.179M |
| Sep 23, 2026 | 2.57 | 2.585 | 2.43 | 2.43 | 909697.0 |
| Sep 22, 2026 | 2.55 | 2.63 | 2.51 | 2.58 | 1.664M |
| Sep 21, 2026 | 2.52 | 2.575 | 2.44 | 2.53 | 1.267M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agenus, Inc. | 6.33 |
| Amgen, Inc. | 439.26 |
| Anika Therapeutics, Inc. | 21.42 |
| BioCryst Pharmaceuticals, Inc. | 7.65 |
| Imunon, Inc. | 1.235 |
Price Related Metrics
| PS Ratio | 38.90 |
| Price to Book Value | 1.605 |
| Earnings Yield | -49.91% |
| Market Cap | 246.22M |